Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × tislelizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Hepatocellular 4 Advanced Solid Tumors 4 Recurrence 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumors 1 Sarcoma 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lung Neoplasms 1 Locally Advanced or Metastatic Urothelial Bladder Cancer 1 Locally Advanced and Metastatic Solid Tumors 1 Limited Stage Small Cell Lung Cancer 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡